Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.16, for a total value of $1,082,320.00. Following the sale, the chief executive officer owned 70,418 shares in the company, valued at $38,107,404.88. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Chemed Stock Performance

Shares of CHE stock traded up $0.92 during trading hours on Monday, reaching $541.49. The stock had a trading volume of 21,011 shares, compared to its average volume of 215,475. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The firm has a 50-day simple moving average of $499.24 and a 200-day simple moving average of $446.50. The firm has a market capitalization of $7.08 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the previous year, the business posted $4.27 EPS. Chemed’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.

Hedge Funds Weigh In On Chemed

Institutional investors have recently made changes to their positions in the business. Geneos Wealth Management Inc. boosted its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after acquiring an additional 4,560 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of Chemed in the 2nd quarter worth approximately $579,000. Brown Advisory Inc. grew its position in Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after acquiring an additional 148 shares during the last quarter. Finally, Cerity Partners LLC increased its holdings in Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after purchasing an additional 3,133 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CHE has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Oppenheimer lifted their price target on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada lifted their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.